The EU's drug watchdog has approved two Covid-19 antibody treatments, in its first approvals of the groundbreaking therapies that help stop infected people developing symptoms of the disease, Reuters reports.
Ronapreve, made by Swiss pharma giant Roche with US biotech firm Regeneron, and Regkirona, developed by South Korea's Celltrion, got the green light from the European Medicines Agency (EMA).
“Ronapreve and Regkirona are the first monoclonal antibody medicines to receive a positive opinion... for Covid-19,” the Amsterdam-based EMA said in a statement.
